Sonoma Pharmaceuticals cuts jobs to slow ‘cash burn’

Specialty drugmaker Sonoma Pharmaceuticals will reduce its workforce in an effort to slow “cash burn.”

Advertisement

The company did not disclose the number of employees it would lay off, but said its cost reduction efforts would primarily target its manufacturing workforce and attempt to shed consulting and manufacturing expenses.

The cost-cutting measures come after the company completed an extensive evaluation of its processes and financials.

“This process takes time and can be painful, and we recognize that personnel reductions are difficult for our employees, their families and the community. We value the dedicated team at Sonoma for working hard towards this goal,” said Bubba Sandford, Sonoma’s CEO.

More articles on pharmacy:
Bristol-Myers urges shareholders to support Celgene takeover
Novartis to pay $23M to settle claims it used charity payments as kickbacks
Martin Shkreli reportedly running his pharma company from prison

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

The Performance Gap Your Pharmacy Training Metrics Can’t See

Monday, August 10
12:00 PM - 1:00 PM CDT

Presenters: Michael Alexander, AudirieDr. Tina Moen, PharmD, Colibri Healthcare

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.